Spremljaj
Mehdi Farhoudi
Mehdi Farhoudi
Professor of Neurology, Fellowship of Stroke, Neurosciences Research Center, World Stroke Board
Preverjeni e-poštni naslov na tbzmed.ac.ir
Naslov
Navedeno
Navedeno
Leto
Amyloid-beta: a crucial factor in Alzheimer's disease
S Sadigh-Eteghad, B Sabermarouf, A Majdi, M Talebi, M Farhoudi, ...
Medical principles and practice 24 (1), 1-10, 2015
6202015
Global impact of COVID-19 on stroke care
RG Nogueira, M Abdalkader, MM Qureshi, MR Frankel, OY Mansour, ...
International journal of stroke 16 (5), 573-584, 2021
1682021
Association of apolipoprotein E epsilon 4 allele with sporadic late onset Alzheimer’s disease. A meta-analysis
S Sadigh-Eteghad, M Talebi, M Farhoudi
Neurosciences Journal 17 (4), 321-326, 2012
1562012
Global impact of COVID-19 on stroke care and IV thrombolysis
RG Nogueira, MM Qureshi, M Abdalkader, SO Martins, H Yamagami, ...
Neurology 96 (23), e2824-e2838, 2021
1462021
Transcranial low-level laser therapy improves brain mitochondrial function and cognitive impairment in D-galactose–induced aging mice
F Salehpour, N Ahmadian, SH Rasta, M Farhoudi, P Karimi, ...
Neurobiology of aging 58, 140-150, 2017
1222017
The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: interleukin-17A and interleukin-17F serum levels
Z Babaloo, MR Aliparasti, F Babaiea, S Almasi, B Baradaran, M Farhoudi
Immunology letters 164 (2), 76-80, 2015
1102015
SARS-CoV-2 and stroke characteristics: a report from the multinational COVID-19 stroke study group
S Shahjouei, G Tsivgoulis, G Farahmand, E Koza, A Mowla, A Vafaei Sadr, ...
Stroke 52 (5), e117-e130, 2021
1012021
Targeting pericytes for neurovascular regeneration
MH Geranmayeh, R Rahbarghazi, M Farhoudi
Cell Communication and Signaling 17 (1), 26, 2019
982019
The efficacy of the ketogenic diet on motor functions in Parkinson’s disease: A rat model
S Shaafi, S Najmi, H Aliasgharpour, J Mahmoudi, S Sadigh-Etemad, ...
Iranian journal of neurology 15 (2), 63, 2016
832016
Does lipoic acid consumption affect the cytokine profile in multiple sclerosis patients: a double-blind, placebo-controlled, randomized clinical trial
M Khalili, A Azimi, V Izadi, S Eghtesadi, A Mirshafiey, MA Sahraian, ...
Neuroimmunomodulation 21 (6), 291-296, 2014
792014
Cognitive rehabilitation improves ischemic stroke-induced cognitive impairment: role of growth factors
F Farokhi-Sisakht, M Farhoudi, S Sadigh-Eteghad, J Mahmoudi, ...
Journal of Stroke and Cerebrovascular Diseases 28 (10), 104299, 2019
762019
Angioplasty and stenting of symptomatic vertebral artery stenosis clinical and angiographic follow-up of 206 cases from Northwest Iran
R Mohammadian, E Sharifipour, R Mansourizadeh, B Sohrabi, AR Nayebi, ...
The neuroradiology journal 26 (4), 454-463, 2013
742013
Photobiomodulation and Coenzyme Q10 Treatments Attenuate Cognitive Impairment Associated With Model of Transient Global Brain Ischemia in Artificially Aged …
F Salehpour, F Farajdokht, J Mahmoudi, M Erfani, M Farhoudi, P Karimi, ...
Frontiers in cellular neuroscience 13, 74, 2019
702019
The emerging value of serum D-dimer measurement in the work-up and management of ischemic stroke
T Ohara, M Farhoudi, OY Bang, M Koga, AM Demchuk
International Journal of Stroke 15 (2), 122-131, 2020
662020
Relation between serum magnesium level and migraine attacks
M Talebi, D Savadi-Oskouei, M Farhoudi, S Mohammadzade, ...
Neurosciences Journal 16 (4), 320-323, 2011
652011
Neurotrophic factors hold promise for the future of Parkinson’s disease treatment: is there a light at the end of the tunnel?
A Nasrolahi, J Mahmoudi, A Akbarzadeh, M Karimipour, ...
Reviews in the Neurosciences 29 (5), 475-489, 2018
642018
Multiple sclerosis and environmental risk factors: a case-control study in Iran
M Abbasi, SM Nabavi, SM Fereshtehnejad, NZ Jou, I Ansari, ...
Neurological Sciences 38, 1941-1951, 2017
582017
Recent advances in targeted delivery of tissue plasminogen activator for enhanced thrombolysis in ischaemic stroke
M Zamanlu, M Farhoudi, M Eskandani, J Mahmoudi, J Barar, M Rafi, ...
Journal of drug targeting 26 (2), 95-109, 2018
572018
Beta-amyloid exhibits antagonistic effects on alpha 7 nicotinic acetylcholine receptors in orchestrated manner
S Sadigh-Eteghad, M Talebi, M Farhoudi, SEJ Golzari, B Sabermarouf, ...
Journal of Medical Hypotheses and Ideas 8 (2), 49-52, 2014
572014
Toxoplasmosis and Alzheimer: can Toxoplasma gondii really be introduced as a risk factor in etiology of Alzheimer?
M Mahami-Oskouei, F Hamidi, M Talebi, M Farhoudi, AA Taheraghdam, ...
Parasitology Research 115, 3169-3174, 2016
562016
Sistem trenutno ne more izvesti postopka. Poskusite znova pozneje.
Članki 1–20